Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,423 | -37,504 | -9,394 | -39,740 | -30,997 |
| Depreciation Amortization | 4,259 | 2,318 | 557 | 214 | 152 |
| Income taxes - deferred | -74 | 33 | 264 | 1,057 | 793 |
| Accounts receivable | -686 | -1,079 | -4,049 | N/A | 0 |
| Accounts payable and accrued liabilities | -5,656 | -4,240 | -2,672 | 8,767 | 5,167 |
| Other Working Capital | 10,196 | 12,599 | -8,893 | 1,053 | 7,433 |
| Other Operating Activity | 18,397 | 13,564 | 11,178 | 2,096 | 2,780 |
| Operating Cash Flow | $-22,986 | $-14,309 | $-13,009 | $-26,553 | $-14,672 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -7,000 | -5,000 | -4,400 | -5,750 | 0 |
| Investing Cash Flow | $-7,000 | $-5,000 | $-4,400 | $-5,750 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,635 | N/A | N/A | 1,300 | 1,300 |
| Common Stock Issued | 34,999 | 20,816 | 20,878 | 32,303 | 16,509 |
| Other Financing Activity | -893 | -1,169 | 0 | -300 | -300 |
| Financing Cash Flow | $42,742 | $19,647 | $20,878 | $33,303 | $17,509 |
| Beginning Cash Position | 4,252 | 4,252 | 4,252 | 3,252 | 3,252 |
| End Cash Position | 17,008 | 4,590 | 7,721 | 4,252 | 6,089 |
| Net Cash Flow | $12,755 | $338 | $3,469 | $1,000 | $2,837 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,986 | -14,309 | -13,009 | -26,553 | -14,672 |
| Free Cash Flow | -22,986 | -14,309 | -13,009 | -26,553 | -14,672 |